Walentyna Balwierz

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

Ruth Ladenstein, Ulrike Pötschger, Andrew D.J. Pearson et al. · The Lancet Oncology · 2017 · 334 citations · Full text

Oncology, Medicine, Versus Carboplatin +8

Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study

Ruth Ladenstein, Dominique Valteau‐Couanet, Penelope Brock et al. · Journal of Clinical Oncology · 2010 · 129 citations

Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study

Keith Holmes, Ulrike Pötschger, Andrew D.J. Pearson et al. · Journal of Clinical Oncology · 2020 · 117 citations · Full text

Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study

Jan Styczyński, K Czyźewski, Mariusz Wysocki et al. · Clinical Microbiology and Infection · 2015 · 99 citations · Full text

Transplantation, Marrow Transplantation, Infection-related Mortality +11

Clinical Impact of Additional Cytogenetic Aberrations, <i>cKIT</i> and <i>RAS</i> Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group

Kim Klein, Gertjan J.L. Kaspers, Christine J. Harrison et al. · Journal of Clinical Oncology · 2015 · 92 citations · Full text